Publication | Open Access
Chimeric antigen receptors that trigger phagocytosis
376
Citations
32
References
2018
Year
ImmunologyDirect MacrophagesImmunologic MechanismAntigen ProcessingImmunotherapeuticsImmune Cell TherapyImmunotherapySynthetic ImmunologyTumor ImmunityChimeric Antigen ReceptorsAutoimmune DiseaseCancer Cell EngulfmentAutoimmunityHumoral ImmunityT Cell ImmunityCell BiologyPhagocyteCancer ImmunosurveillanceMedicine
Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T cells to kill cancer. The success of CAR-T cell therapies highlights the promise of programmed immunity and suggests that applying CAR strategies to other immune cell lineages may be beneficial. Here, we engineered a family of Chimeric Antigen Receptors for Phagocytosis (CAR-Ps) that direct macrophages to engulf specific targets, including cancer cells. CAR-Ps consist of an extracellular antibody fragment, which can be modified to direct CAR-P activity towards specific antigens. By screening a panel of engulfment receptor intracellular domains, we found that the cytosolic domains from Megf10 and FcRɣ robustly triggered engulfment independently of their native extracellular domain. We show that CAR-Ps drive specific engulfment of antigen-coated synthetic particles and whole human cancer cells. Addition of a tandem PI3K recruitment domain increased cancer cell engulfment. Finally, we show that CAR-P expressing murine macrophages reduce cancer cell number in co-culture by over 40%.
| Year | Citations | |
|---|---|---|
Page 1
Page 1